DOC
Healthpeak Properties, Inc. NYSE Listed May 23, 1985$21.10
Pre-mkt
$21.14
+0.19%
Mkt Cap $14.5B
52w Low $15.70
74.5% of range
52w High $22.95
50d MA $21.09
200d MA $18.28
P/E (TTM)
57.3x
EV/EBITDA
13.6x
P/B
1.8x
Debt/Equity
1.4x
ROE
0.9%
P/FCF
12.8x
RSI (14)
31.70
ATR (14)
$0.53
Beta
1.08
50d MA
$21.09
200d MA
$18.28
Avg Volume
6.6M
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
4600 South Syracuse Street · Denver, CO 80237 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | AMC | 0.03 | 0.46 | +1534.3% | 21.62 | +1.8% | +0.8% | -3.2% | — | — | — | — |
| May 5, 2026 | AMC | 0.05 | 0.28 | +430.6% | 16.51 | +2.7% | +18.1% | +0.8% | -0.1% | +0.6% | +0.1% | — |
| Feb 2, 2026 | AMC | 0.45 | 0.47 | +4.4% | 16.92 | -2.5% | -2.8% | +2.0% | -0.6% | +1.0% | -0.1% | — |
| Oct 23, 2025 | AMC | 0.45 | 0.46 | +2.2% | 18.54 | +1.0% | +1.2% | +1.6% | -5.4% | -2.5% | -0.1% | — |
| Jul 24, 2025 | AMC | 0.46 | 0.46 | +0.0% | 18.87 | -2.5% | -6.7% | -1.9% | +0.6% | -0.9% | -1.6% | — |
| Apr 24, 2025 | AMC | 0.46 | 0.46 | +0.0% | 18.81 | +0.0% | -5.2% | -0.4% | +0.1% | +0.5% | -0.3% | — |
| Feb 3, 2025 | AMC | 0.05 | 0.46 | +820.0% | 20.38 | -1.8% | -1.6% | -0.1% | +0.4% | -1.3% | -1.4% | — |
| Oct 24, 2024 | AMC | 0.44 | 0.45 | +2.3% | 23.00 | -1.5% | -3.1% | +1.3% | -0.3% | +0.9% | -1.2% | — |
| Jul 25, 2024 | AMC | 0.44 | 0.45 | +2.3% | 20.76 | +5.5% | +5.5% | -0.2% | -0.0% | -0.1% | -0.4% | — |
| Apr 25, 2024 | AMC | 0.44 | 0.45 | +2.3% | 18.34 | +0.7% | +2.5% | +0.7% | -1.7% | +1.5% | +1.5% | — |
| Feb 8, 2024 | AMC | 0.45 | 0.46 | +2.2% | 17.99 | -1.9% | -3.6% | +1.2% | -4.3% | +0.5% | +3.6% | — |
| Oct 30, 2023 | AMC | 0.44 | 0.45 | +2.3% | 15.98 | +1.1% | -2.7% | +0.2% | +8.0% | +2.3% | -2.6% | — |
| Jul 27, 2023 | AMC | 0.44 | 0.45 | +2.3% | 21.82 | +2.2% | -0.4% | +0.5% | -0.6% | -0.4% | -0.4% | — |
| Apr 27, 2023 | AMC | 0.42 | 0.42 | +0.0% | 21.21 | +2.0% | +3.6% | -1.5% | -2.1% | +0.5% | +0.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 7 | Barclays | Initiates | Equal Weight | $23 | $21.75 | $21.91 | +0.7% | +0.8% | -0.7% | -0.9% | +0.4% | +0.4% |
| Jun 17 | Raymond James | Reiterates | Mkt Perform | — | $20.09 | $20.03 | -0.3% | -3.4% | +0.8% | +2.1% | +2.9% | +1.3% |
| Jun 11 | Morgan Stanley | Downgrade | Overweight → Equal-Weight | $22 | $20.47 | $20.30 | -0.8% | +0.1% | +0.9% | -1.3% | -1.7% | -3.4% |
| May 11 | Evercore ISI | Downgrade | Outperform → In-line | $21 | $19.64 | $19.55 | -0.5% | +0.6% | +0.1% | -1.2% | +0.1% | -1.0% |
| Apr 28 | Morgan Stanley | Maintains | Overweight → Overweight | — | $16.20 | $16.23 | +0.2% | -0.9% | -0.4% | +1.1% | +1.5% | -0.8% |
| Apr 6 | Baird | Maintains | Outperform → Outperform | — | $16.52 | $16.37 | -0.9% | +0.9% | +1.3% | -1.2% | +0.1% | +0.3% |
| Apr 1 | Citigroup | Maintains | Neutral → Neutral | — | $16.43 | $16.40 | -0.2% | -0.3% | +0.9% | +0.9% | +1.3% | -1.2% |
| Feb 5 | Argus | Downgrade | Buy → Hold | — | $16.78 | $16.78 | +0.0% | -0.6% | +1.0% | -0.1% | +1.0% | -0.2% |
| Feb 4 | Evercore ISI | Maintains | Outperform → Outperform | — | $16.45 | $16.51 | +0.4% | +2.0% | -0.6% | +1.0% | -0.1% | +1.0% |
| Feb 2 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $17.24 | $17.18 | -0.3% | -1.9% | -2.8% | +2.0% | -0.6% | +1.0% |
| Dec 16 | Jefferies | Downgrade | Buy → Hold | — | $16.66 | $16.48 | -1.1% | -1.8% | +0.2% | +0.1% | -2.6% | +0.3% |
| Dec 15 | Evercore ISI | Maintains | Outperform → Outperform | — | $16.62 | $16.69 | +0.4% | +0.2% | -1.8% | +0.2% | +0.1% | -2.6% |
| Nov 25 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $17.85 | $17.95 | +0.6% | +1.5% | +0.6% | +0.2% | -0.4% | -0.8% |
| Nov 12 | Baird | Maintains | Outperform → Outperform | — | $17.90 | $17.80 | -0.6% | -1.5% | -0.7% | -0.9% | -0.3% | +2.3% |
| Sep 15 | Raymond James | Upgrade | Market Perform → Outperform | — | $18.08 | $18.27 | +1.1% | +0.9% | -0.1% | -0.1% | +2.0% | -0.5% |
| Aug 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $17.53 | $17.57 | +0.2% | +2.1% | -0.2% | +0.4% | +0.1% | -1.2% |
| Aug 22 | Morgan Stanley | Maintains | Overweight → Overweight | — | $17.28 | $17.38 | +0.6% | +2.7% | -0.6% | -0.7% | +2.1% | -0.2% |
| Aug 20 | Deutsche Bank | Downgrade | Buy → Hold | — | $17.22 | $17.18 | -0.2% | +0.0% | +0.3% | +2.7% | -0.6% | -0.7% |
| Jul 30 | Baird | Maintains | Outperform → Outperform | — | $17.37 | $17.40 | +0.2% | -0.9% | -1.6% | -1.0% | +0.8% | +1.7% |
| Jul 29 | Scotiabank | Downgrade | Sector Outperform → Sector Perform | — | $17.26 | $17.10 | -0.9% | +0.6% | -0.9% | -1.6% | -1.0% | +0.8% |
| Jun 2 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $17.41 | $17.30 | -0.6% | +0.0% | -1.5% | -0.3% | -0.1% | +1.1% |
| May 12 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $17.47 | $17.59 | +0.7% | +0.5% | -1.7% | -1.6% | +2.0% | +2.4% |
| Apr 29 | Argus | Maintains | Buy → Buy | — | $17.75 | $17.83 | +0.5% | +0.1% | +0.5% | -0.3% | +0.2% | -1.3% |
| Apr 29 | Baird | Maintains | Outperform → Outperform | — | $17.75 | $17.83 | +0.5% | +0.1% | +0.5% | -0.3% | +0.2% | -1.3% |
| Apr 28 | Evercore ISI | Maintains | Outperform → Outperform | — | $17.83 | $17.79 | -0.2% | -0.4% | +0.1% | +0.5% | -0.3% | +0.2% |
| Apr 28 | Wedbush | Maintains | Outperform → Outperform | — | $17.83 | $17.79 | -0.2% | -0.4% | +0.1% | +0.5% | -0.3% | +0.2% |
| Apr 11 | Wedbush | Maintains | Outperform → Outperform | — | $18.17 | $18.01 | -0.9% | -0.1% | +3.0% | +0.3% | -1.0% | +0.9% |
| Feb 28 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $20.18 | $20.31 | +0.6% | +1.4% | -0.3% | -0.7% | +0.8% | -1.4% |
| Feb 14 | Wedbush | Maintains | Outperform → Outperform | — | $19.96 | $19.69 | -1.4% | -1.9% | -0.1% | -0.4% | +1.4% | -0.2% |
| Feb 11 | Baird | Maintains | Outperform → Outperform | — | $19.59 | $19.43 | -0.8% | +0.1% | -0.8% | +2.6% | -1.9% | -0.1% |
| Dec 10 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $21.70 | $21.60 | -0.5% | -1.2% | -0.8% | -1.6% | -0.8% | -0.2% |
| Dec 5 | Mizuho | Maintains | Outperform → Outperform | — | $21.30 | $21.07 | -1.1% | +0.9% | -0.5% | +1.5% | -1.2% | -0.8% |
| Nov 4 | RBC Capital | Maintains | Outperform → Outperform | — | $21.98 | $21.76 | -1.0% | +0.0% | +2.4% | -0.8% | +1.0% | +0.9% |
| Oct 30 | Baird | Maintains | Outperform → Outperform | — | $22.52 | $22.59 | +0.3% | +0.9% | -1.2% | -2.1% | +0.0% | +2.4% |
| Jul 30 | RBC Capital | Maintains | Outperform → Outperform | — | $21.85 | $21.87 | +0.1% | -0.0% | -0.1% | -0.4% | -0.9% | -3.7% |
| Jul 29 | Wedbush | Maintains | Outperform → Outperform | — | $21.90 | $21.88 | -0.1% | -0.2% | -0.0% | -0.1% | -0.4% | -0.9% |
| May 16 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $20.25 | $20.25 | +0.0% | -1.4% | -0.4% | -0.5% | -0.2% | -1.2% |
| May 16 | JP Morgan | Maintains | Neutral → Neutral | — | $20.25 | $20.25 | +0.0% | -1.4% | -0.4% | -0.5% | -0.2% | -1.2% |
| May 3 | Wedbush | Upgrade | Neutral → Outperform | — | $19.17 | $19.26 | +0.5% | -1.0% | +0.0% | +1.2% | -0.3% | +1.6% |
| Apr 10 | RBC Capital | Maintains | Outperform → Outperform | — | $19.34 | $18.68 | -3.4% | -3.4% | +0.0% | -0.9% | -1.2% | -2.6% |
| Apr 1 | BofA Securities | Upgrade | Underperform → Buy | — | $18.75 | $19.28 | +2.8% | -1.1% | -1.6% | +0.7% | -0.3% | +1.6% |
| Mar 4 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $17.10 | $16.89 | -1.2% | -1.5% | +1.1% | +3.1% | -0.2% | +1.1% |
| Jan 12 | Scotiabank | Upgrade | Sector Perform → Sector Outperform | — | $20.29 | $20.61 | +1.6% | +2.7% | -0.5% | -3.3% | -2.2% | +0.8% |
| Jan 5 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $19.66 | $19.46 | -1.0% | -0.2% | +1.8% | -0.4% | +0.4% | +1.6% |
| Jan 2 | Compass Point | Maintains | Buy → Buy | — | $19.80 | $19.79 | -0.1% | +1.2% | -2.2% | +0.4% | -0.2% | +1.8% |
| Dec 22 | Truist | Maintains | Hold → Hold | — | $19.40 | $19.43 | +0.2% | +1.5% | +1.3% | +0.3% | +0.8% | -1.9% |
| Oct 31 | Wedbush | Maintains | Neutral → Neutral | — | $15.98 | $16.16 | +1.1% | -2.7% | +0.2% | +8.0% | +2.3% | -2.6% |
| Oct 5 | Scotiabank | Maintains | Sector Perform → Sector Perform | — | $17.49 | $17.43 | -0.3% | -0.6% | -0.7% | +1.6% | +2.2% | +1.2% |
| Sep 7 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $20.41 | $20.33 | -0.4% | -1.4% | -0.5% | -1.3% | +0.9% | -0.4% |
| Aug 21 | Citigroup | Maintains | Neutral → Neutral | — | $20.09 | $20.00 | -0.4% | -1.1% | -0.2% | +2.1% | -0.1% | +0.0% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | Bohn Scott ROff | CDO and Head of Lab | Sell | 10,989 | $19.45 | $214K | 7,636 | +0.05% | +1.87% |
8-K · 2.02
!! High
Healthpeak Properties, Inc. -- 8-K 2.02: Earnings Results
Aug 4
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Governance / Corporate
Healthpeak Properties agreed to restructure operations with its operating partner, potentially streamlining management and reducing costs, which could improve profitability and distributions to shareholders.
Mar 23
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
I need more specific details about the financing/debt agreement to provide meaningful analysis. Could you clarify: which company (BAC or DOC), the debt amount, terms, interest rate, or whether this is new debt issuance or restructuring?
Mar 23
8-K · 7.01
! Medium
Healthpeak Properties, Inc. -- 8-K 7.01: Regulation FD Disclosure
Healthpeak Properties CEO Scott Brinker will present at the Citi 2026 Global Property CEO Conference on March 3, 2026, with a live webcast available on the company's investor relations website.
Feb 27
8-K · 7.01
! Medium
Healthpeak Properties, Inc. -- 8-K 7.01: Regulation FD Disclosure
Healthpeak Properties disclosed its Q4 2025 and full-year 2025 financial results, providing investors updated performance metrics and operational data through regulatory filing.
Feb 2
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Portfolio Management Llc | 58,125,899 | $955M | New | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 45,218,927 | $743M | New | Mar 2026 |
| 3 | Jpmorgan Chase & Co | 44,731,541 | $740M | Added | Mar 2026 |
| 4 | Principal Financial Group Inc | 26,681,771 | $429M | Reduced | Dec 2025 |
| 5 | Invesco Ltd. | 24,167,474 | $397M | Added | Mar 2026 |
| 6 | Morgan Stanley | 24,502,688 | $394M | Added | Dec 2025 |
| 7 | Bank Of New York Mellon Corp | 15,456,420 | $254M | Added | Mar 2026 |
| 8 | Bank Of America Corp /de/ | 11,887,795 | $195M | Added | Mar 2026 |
| 9 | Fmr Llc | 9,261,007 | $152M | Reduced | Mar 2026 |
| 10 | Northern Trust Corp | 8,571,748 | $141M | Added | Mar 2026 |
| 11 | Equity Investment Corp | 7,665,233 | $126M | Added | Mar 2026 |
| 12 | Alyeska Investment Group, L.p. | 5,616,667 | $92M | New | Mar 2026 |
| 13 | Franklin Resources Inc | 4,510,533 | $74M | Added | Mar 2026 |
| 14 | Russell Investments Group, Ltd. | 4,410,014 | $72M | Added | Mar 2026 |
| 15 | Amundi | 3,784,577 | $62M | New | Mar 2026 |
| 16 | Ubs Group Ag | 3,618,083 | $59M | Added | Mar 2026 |
| 17 | Millennium Management | 3,258,558 | $54M | Reduced | Mar 2026 |
| 18 | Raymond James Financial Inc | 2,893,568 | $48M | Added | Mar 2026 |
| 19 | Barclays Plc | 2,598,317 | $43M | Added | Mar 2026 |
| 20 | Cbre Investment Management Listed Real Assets Llc | 2,543,209 | $42M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$14.55B
Enterprise Value
$24.29B
P/E (TTM)
57.33x
Forward P/E
100.72x
PEG Ratio
-2.17x
P/B
1.77x
P/S
4.93x
P/FCF
12.81x
EV/EBITDA
13.63x
Shares Out
696.0M
Financials (TTM)
Revenue
$2.95B
Net Income
$253.7M
EBITDA
$1.78B
Free Cash Flow
$1.15B
Op Cash Flow
$1.28B
EPS Basic
$0.10
EPS Diluted
$0.35
EPS Forward
$0.21
Gross Margin
2.5%
Op Margin
17.6%
Net Margin
8.6%
Balance Sheet
Total Assets
$20.34B
Total Liab.
$12.03B
Total Equity
$8.30B
Cash
$537.7M
LT Debt
$10.14B
Book Value/Sh
$11.93
Debt/Equity
1.39x
Current Ratio
1.09
Quick Ratio
1.09
Returns & Growth
ROE
0.9%
ROA
0.4%
ROIC
37.3%
Rev Growth YoY
+4.5%
EPS Growth YoY
-72.2%
Price Returns
2W
-4.4%
1M
-3.8%
3M
+7.3%
6M
+25.2%
12M
+24.4%
Technicals
52W High
$22.95
52W Low
$15.70
50d MA
$21.09
200d MA
$18.28
RSI (14)
31.70
ATR (14)
$0.53
Beta
1.08
Avg Volume
6.6M
Dividends
Div Rate
$1.22
Div Yield
7.4%
Frequency
12
Ex-Div Date
Jun 15, 2026
Analyst Price Targets
Consensus
$17.86
High
$21.00
Low
$17.00
Median
$17.00
Data updated apr 25, 2026 5:34am
· Source: financialmodelingprep.com